Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 3/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 5/20 | 0.41 |
| ▸ | CTSD | P07339 | 3/20 | 0.41 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.41 |
| ▸ | TFPI | P10646 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30629771 | 0.87 | NPY4R (0.45) | FURINBACE1CTSDPCSK6 | |
| SCHEMBL29912721 | 0.86 | FURIN (0.47) | FURINPRSS1BACE1CTSD | |
| SCHEMBL30824280 | 0.86 | BACE1 (0.48) | FURINPRSS1BACE1CTSD | |
| SCHEMBL31299908 | 0.84 | TFPI (0.46) | FURINBACE1TFPI | |
| SCHEMBL30531774 | 0.84 | GSR (0.42) | FURINPRSS1BACE1CTSD | |
| SCHEMBL28081113 | 0.84 | BACE1 (0.49) | FURINBACE1CTSD | |
| SCHEMBL31299907 | 0.83 | OPRM1 (0.46) | FURINBACE1CTSDTFPI | |
| SCHEMBL28081212 | 0.83 | EGFR (0.49) | FURINBACE1CTSDTFPI | |
| SCHEMBL30532205 | 0.83 | FURIN (0.49) | FURINPRSS1BACE1CTSD | |
| SCHEMBL29531524 | 0.82 | NTSR2 (0.45) | FURINBACE1CTSDPCSK6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731674-A2 | COMPOSITIONS AND METHODS FOR BINDING TO COVALENT PEPTIDE CONJUGATES | New York University (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260109958-A1 | T-Cell Modulatory Polypeptides and Methods of Use Thereof | CUE BIOPHARMA INC (US) | 2026-04-23 | — | — | US | claimed |
| EP-4656655-A1 | TCR MOLECULES TARGETING KRAS MUTATION, CELLS AND USE OF TCR MOLECULES AND CELLS | Beijing DCTY Biotech Co., Ltd. (CN) | 2025-12-03 | — | — | EP | claimed |
| US-20250353912-A1 | COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES | UNIV NEW YORK (US) | 2025-11-20 | — | — | US | claimed |
| WO-2025226775-A2 | COMPOSITIONS AND METHODS FOR BINDING TO COVALENT PEPTIDE CONJUGATES | NEW YORK UNIVERSITY (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250269002-A1 | CTA VACCINE CASSETTES | GRITSTONE BIO INC (US) | 2025-08-28 | — | — | US | claimed |
| EP-4565264-A2 | CTA VACCINE CASSETTES | Gritstone bio, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| EP-4543931-A2 | COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES | New York University (US) | 2025-04-30 | — | — | EP | claimed |
| WO-2024031027-A9 | CTA VACCINE CASSETTES | GRITSTONE BIO, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| CN-119866347-A | Compositions and methods comprising antibodies conjugated to covalent peptide conjugates | 纽约大学 | 2025-04-22 | — | — | CN | claimed |
| EP-4106785-A1 | MOLECULES TARGETING MUTANT RAS PROTEIN | Aelin Therapeutics (BE) | 2022-12-28 | — | — | EP | claimed |
| CN-115175934-A | Antigen binding proteins targeting consensus neoantigens | 磨石生物公司 | 2022-10-11 | — | — | CN | claimed |
| WO-2022197971-A1 | T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | CUE BIOPHARMA, INC. (US) | 2022-09-22 | — | — | WO | claimed |
| EP-4058484-A2 | ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENS | Gritstone bio, Inc. (US) | 2022-09-21 | — | — | EP | claimed |
| EP-4030897-A1 | T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. (US) | 2022-07-27 | — | — | EP | claimed |
| WO-2022099156-A2 | T-CELL MODULATORY POLYPEPTIDES WITH CONJUGATION SITES AND METHODS OF USE THEREOF | CUE BIOPHARMA, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| WO-2022099157-A1 | ANTIGEN PRESENTING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | CUE BIOPHARMA, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| US-20220143063-A1 | T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | CUE BIOPHARMA, INC. | 2022-05-12 | — | — | US | claimed |
| CN-114423284-A | T cell modulating polypeptides and methods of use thereof | 库尔生物制药有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-114026116-A | RAS neoantigen specific binding proteins and uses thereof | 弗雷德哈钦森癌症研究中心 | 2022-02-08 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220143063-A1 | T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | MICA, CD74, HLA-DRB1 | FURIN 420/4885PRSS1 196/4885BACE1 547/4885 |
| US-20260109958-A1 | T-Cell Modulatory Polypeptides and Methods of Use Thereof | CD74, KRAS, MICA | FURIN 777/4885PRSS1 1590/4885BACE1 992/4885 |
| US-20250353912-A1 | COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES | MICA, CD74, HLA-DRB1 | FURIN 556/4885PRSS1 3160/4885BACE1 1889/4885 |
| US-20250269002-A1 | CTA VACCINE CASSETTES | KRAS, TP53, TSG101 | FURIN 264/4885PRSS1 795/4885BACE1 4308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.